FBXW7 regulates a mitochondrial transcription program by modulating MITF

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• FBXW7 acts as a tumor suppressor in various cancers, including melanoma.
• The precise mechanisms underlying FBXW7's tumor-suppressive role in melanoma remain incompletely understood.

Purpose of the Study:

• To elucidate the transcriptomic changes regulated by FBXW7 in melanoma.
• To investigate the functional relationship between FBXW7, MITF, and mitochondrial metabolism in melanoma.

Main Methods:

• RNA sequencing of human melanoma cell lines with FBXW7 silenced (n=10).
• Analysis of a human melanoma tumor cohort (n=51).
• In vitro studies assessing the impact of FBXW7 and MITF manipulation.

Main Results:

• Loss of FBXW7 significantly enhances a mitochondrial gene transcriptional program in melanoma.
• This FBXW7-regulated program is dependent on MITF (microphthalmia-associated transcription factor).
• FBXW7 inactivation leads to elevated MITF protein levels and is an upstream regulator of the MITF/PGC-1 signaling pathway, correlating with poor patient prognosis.

Conclusions:

• FBXW7 loss promotes a mitochondrial metabolic phenotype in melanoma through MITF.
• Targeting FBXW7 or the MITF/PGC-1 pathway may offer therapeutic strategies for melanoma.
• Understanding FBXW7's role is crucial for deciphering melanoma progression and identifying novel therapeutic targets.